 |
|
Booster Vaccination With Further Live Attenuated Measles Vaccine
COL James W. Bass, MC;
Scott B. Halstead, MD;
MAJ Gerald W. Fischer, MC;
MAJ John K. Podgore, MC;
MAJ William R. Pearl, MC;
MAJ Manuel Schydlower, MC;
Robert A. Wiebe, MD;
Frederick M. Ching
JAMA. 1976;235(1):31-34.
Abstract
Revaccination with live attenuated measles vaccine was evaluated in a large group of children to determine (1) if protective antibody to measles infection could be augmented and (2) after what interval will the revaccination yield optimal results. The rate of decline in measles hemagglutination-inhibition (HI) antibody was observed to be directly related to the time interval since the previous vaccination, and individuals with declining titers became increasingly responsive to revaccination with a maximal response approximately four to six years after previous vaccination. Six-month follow-up studies demonstrated sustained elevations in measles HI antibody titers. Measles-neutralizing antibody showed less tendency to sustain a titer increase after revaccination. These observations suggest that revaccination with live, further attenuated measles vaccine is safe and may augment immunity.
(JAMA 235:31-34, 1976)
Author Affiliations
USA; USA; USA; USA; USA
From the Department of Pediatrics, Tripler Army Medical Center (COL Bass, MAJ Fischer, MAJ Podgore, MAJ Pearl, and MAJ Schydlower), and the departments of pediatrics (Dr Wiebe and Mr Ching) and tropical medicine and medical microbiology (Dr Halstead), University of Hawaii School of Medicine, Honolulu. COL Bass is now with the Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC.
Footnotes
Reprint requests to Department of Pediatrics, Walter Reed Army Medical Center, 6825 16th St NW, Washington, DC 20012 (COL Bass).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Comparative Analysis of Titers of Antibody against Measles Virus in Sera of Vaccinated and Naturally Infected Japanese Individuals of Different Age Groups
Itoh et al.
J. Clin. Microbiol. 2002;40:1733-1738.
ABSTRACT
| FULL TEXT
Assessment of Susceptibility to Measles and Rubella
Preblud et al.
JAMA 1982;247:1134-1137.
ABSTRACT
Measles Vaccination in Young Adults
PREBLUD et al.
ANN INTERN MED 1980;92:132-133.
ABSTRACT
Measles: Ready for Eradication?
RAND and REUMAN
ANN INTERN MED 1979;90:978-980.
ABSTRACT
(Continued from page 156)
CLIN PEDIATR 1979;18:161-167.
Oral Polio Vaccine: Effect of Booster Vaccination One to 14 Years After Primary Series
Bass et al.
JAMA 1978;239:2252-2255.
ABSTRACT
Measles Revaccination: Persistence and Degree of Antibody Titer by Type of Immune Response
Deseda-Tous et al.
Arch Pediatr Adolesc Med 1978;132:287-290.
ABSTRACT
|
